Vaxcyte to Host Webcast and Conference Call to Present Topline Results from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older
September 02, 2024 18:40 ET
|
Vaxcyte, Inc.
SAN CARLOS, Calif., Sept. 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...
Praxis Precision Medicines to Announce Topline Data from the Phase 2 EMBOLD Study of Relutrigine (PRAX-562) in SCN2A and SCN8A Developmental and Epileptic Encephalopathies on September 3, 2024
September 02, 2024 17:00 ET
|
Praxis Precision Medicines, Inc.
BOSTON, Mass., Sept. 02, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of...
Nyxoah Sonne la Cloche de Clôture sur le Nasdaq alors qu'elle se Prépare à Lancer sa Technologie Innovante pour l'Apnée du Sommeil sur le Marché Américain
September 02, 2024 16:05 ET
|
Nyxoah
Nyxoah Sonne la Cloche de Clôture sur le Nasdaq alors qu'elle se Prépare à Lancer sa Technologie Innovante pour l'Apnée du Sommeil sur le Marché Américain L'entreprise a complété la demande...
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
September 02, 2024 16:05 ET
|
Nyxoah
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device FDA regulatory submission for the Company’s Genio® device is complete, U.S. approval...
Sify becomes First in India to Achieve NVIDIA DGX-Ready Data Center Certification for Liquid Cooling to Enable Breakthrough AI Performance
September 02, 2024 07:34 ET
|
Sify Technologies Limited
CHENNAI, India, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Sify Technologies Limited (NASDAQ: SIFY), India’s leading Digital ICT solutions provider with global service capabilities spanning data center,...
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 02, 2024 07:30 ET
|
Abeona Therapeutics Inc.
CLEVELAND, Sept. 02, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity...
Supporting Digital Skills Development: Beeline Kazakhstan Adds New Secondary School to Award-Winning CSR Programme
September 02, 2024 04:00 ET
|
VEON Ltd.
Amsterdam and Almaty, 2 September 2024 – VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON), a global digital operator that provides connectivity and online services (“VEON” or the “Company”),...
Golar LNG Limited – Fixed income investor meetings
September 02, 2024 01:20 ET
|
Golar LNG
Golar LNG Limited (“Golar”) has mandated DNB Markets and Pareto Securities as Global Coordinators and Joint Bookrunners, and Clarksons Securities and Fearnley Securities as Joint Bookrunners, to...
Belite Bio Mengumumkan Pelantikan Hendrik P. N. Scholl, MD, MA, sebagai Ketua Pegawai Perubatan
September 01, 2024 20:00 ET
|
Belite Bio, Inc
Dr. Scholl adalah pemimpin yang diiktiraf di peringkat global dalam bidang oftalmologi dan penyelidik utama penyelaras bagi kajian sejarah semula jadi terbesar bagi penyakit Stargardt. SAN DIEGO,,...
Belite Bio, 최고 의학 책임자로 Hendrik P. N. Scholl 박사 선임 발표
September 01, 2024 19:00 ET
|
Belite Bio, Inc
안과 분야에서 세계적으로 인정받는 권위자인 Scholl 박사는 스타가르트 질환 관련 사상 최대 규모의 자연사 연구 공동 책임 연구자로도 활동 중 샌디에고, Sept. 02, 2024 (GLOBE NEWSWIRE) -- 임상 단계 바이오 의약품 개발 기업인 벨라이트 바이오(Belite Bio, Inc)(나스닥: BLTE)(이하 '벨라이트 바이오'...